Обратиться
Kitazato is one of the leading manufacturers of products for Human Assisted Reproduction Treatments and it is recognized as a leader in the Research and Development of new devices and techniques to combat infertility.
CRYOTOP®
Not only the best proven results
Now also the best user experience
Developed and manufactured in Japan
Program
News
/ A study by Create Fertility UK shows that thaw, biopsy and refreeze with the Cryotop® Method is effective
Patients wishing to have PGT-A on previously cryopreserved embryos are currently limited from accessing this technique due to the requirement for refreezing of the embryos. Embryo cryopreservation techniques have, however, significantly improved in the recent years due the introduction […]
/ Kitazato Best Practice Recognition
This program recognizes those Kitazato Cryotop® Method users with outstanding cryopreservation programs and remarkable clinical results. The Best Practice Recognition is awarded annual, starting in 2021, through which Kitazato rewards its high-performing users, acknowledging their dedication and […]
/ Number of embryos or oocytes per Cryotop® does not influence cooling rates during vitrification
During Fertility 2021, an interesting poster was presented by researchers from Cardiff University and London Women’s Clinic. The number of oocytes or embryos to be loaded onto the Cryotop® and the spatial arrangement on the strip is often a matter […]
